Insights On Facility Design

  1. Transforming Your Biopharma Automation Capabilities 6/24/2021

    Single-use technology equipped with a scalable distributed control system allows for collecting and sharing data while simultaneously creating a connected enterprise that grows with the pace of business.

  2. Vaccines Development, Regulations And Manufacturing Part-2 3/25/2021

    In Part 2, we will review vaccine processes with examples based upon influenza vaccine, inactivated Polio vaccine and an overview of the different types of vaccine production processes from cell expansion, USP and DSP, to the formulation and filling operations to make the finished product. We will talk about vaccine production facilities, how equipment is integrated their operating principles and biological safety levels for containment. Finally, we will look at the vaccine industry today, the supply chain and globalization, and how important vaccines are in pandemic preparedness, availability, and time to market.

  3. Improve Bioprocessing Efficiency With A Standardized Automation Platform 3/9/2021

    Designed specifically for the biomanufacturing industry, Cytiva's Figurate automation is a portfolio of automation platform solutions powered by the reliability of Emerson’s DeltaV.

  4. Integrated Manufacturing: Chromatography Meets Predesigned DeltaV 3/9/2021

    Cytiva’s pre-defined automation solution, Figurate, is now available as a turnkey solution by combining our industry-leading ÄKTA process chromatography system with the reliability of the DeltaV DCS platform.

  5. Achieving Business Continuity In Pharma During COVID-19 Restrictions 3/4/2021

    To ensure business continuity during COVID-19 restrictions, we developed a virtual factory acceptance testing solution that allowed SaudiVax to advance their manufacturing plan.

  6. Prepare For Future Viral Vector Manufacturing 3/1/2021

    Rethinking how we transition from translational clinical centers at smaller scale—using flasks and open systems—towards commercial production and methodologies.

  7. Effectively Managing Data In Process Development 1/11/2021

    Addressing data management challenges during drug development requires an understanding of today’s shortcomings and the factors to consider when adopting a solution to overcome them.

  8. Covid-19 Impact On Bioprocessing: PART 3 Long-Term Changes 11/6/2020

    Although suppliers have proven themselves rather robust in their dealing with the pandemic and business is continuing generally uninterrupted, there will be significant long-term changes.

  9. Re-Imagining Vaccine Manufacturing To Address Global Health Challenges 10/27/2020

    In the last decade, biopharmaceutical industries have mobilized quickly in response to pandemics. Developing vaccines and manufacturing large doses in response to an emergency is often constrained by existing platforms and facility configurations. Learn how vaccine manufacturing can evolve to tackle future global health challenges.

  10. COVID-19 Impact On Bioprocessing: PART 1 Accelerating Trends 10/21/2020

    Because of the urgent demand for treatments, vaccines and assays, the pharmaceutical and biotech industries are experiencing disruptive, often chaotic, increased demands on resources.